EichorEICHOR
Location: Temecula Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Temecula

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Inland Psychiatric Medical Group /ID# 273471 · AbbVie · NCT07220460A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Dep
Phase 2 · Inland Psychiatric Medical Group /ID# 279275 · AbbVie · NCT07276997A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · Medvin Clinical Research - Temecula · Eli Lilly and Company · NCT06864026Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Phase 2 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07365462At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
NA · Southland Arthritis & Osteoporosis Medical Center · SecondWave Systems Inc. · NCT07163221Study of ALTO-300 in MDD
Phase 2 · Site 197 · Alto Neuroscience · NCT05922878MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Innovative Pain Treatment Surgery Center · Stryker Instruments · NCT03072927A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Ery
Phase 4 · GSK Investigational Site · GlaxoSmithKline · NCT06411249A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Sys
Phase 3 · Research Site · AstraZeneca · NCT07430306Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Phase 1 · Southland Arthritis Clinic · Neutrolis · NCT07237659A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adu
Phase 1 · Pa0019 126 · UCB Biopharma SRL · NCT07290036Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in
Phase 2 · Inland Psychiatric Medical Group /ID# 268598 · AbbVie · NCT06846320
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.